TW200633998A - Substituted heterocyclic compounds and thrombopoietin receptor activators - Google Patents

Substituted heterocyclic compounds and thrombopoietin receptor activators

Info

Publication number
TW200633998A
TW200633998A TW094143200A TW94143200A TW200633998A TW 200633998 A TW200633998 A TW 200633998A TW 094143200 A TW094143200 A TW 094143200A TW 94143200 A TW94143200 A TW 94143200A TW 200633998 A TW200633998 A TW 200633998A
Authority
TW
Taiwan
Prior art keywords
sup
substituted heterocyclic
heterocyclic compounds
thrombopoietin receptor
receptor activators
Prior art date
Application number
TW094143200A
Other languages
English (en)
Chinese (zh)
Inventor
Katsuaki Miyaji
Shunsuke Iwamoto
Hirofumi Ota
Yukihiro Shigeta
Yutaka Hirokawa
Satoshi Nakano
Norihisa Ishiwata
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW200633998A publication Critical patent/TW200633998A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW094143200A 2004-12-08 2005-12-07 Substituted heterocyclic compounds and thrombopoietin receptor activators TW200633998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004355079 2004-12-08

Publications (1)

Publication Number Publication Date
TW200633998A true TW200633998A (en) 2006-10-01

Family

ID=36578053

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094143200A TW200633998A (en) 2004-12-08 2005-12-07 Substituted heterocyclic compounds and thrombopoietin receptor activators

Country Status (3)

Country Link
JP (1) JPWO2006062247A1 (ja)
TW (1) TW200633998A (ja)
WO (1) WO2006062247A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1947101A4 (en) * 2005-11-07 2009-09-16 Nissan Chemical Ind Ltd HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
EP2228435A4 (en) * 2007-12-05 2013-01-23 Nissan Chemical Ind Ltd METHOD FOR AMPLIFYING HEMATOPOIETIC STRAIN CELL USING HETEROCYCLIC COMPOUND
US20100310535A1 (en) * 2007-12-05 2010-12-09 Nissan Chemical Industries, Ltd. Method for expanding hematopoietic stem cells using heterocyclic compound
JP5573161B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
US9527828B2 (en) * 2007-12-06 2016-12-27 Nissan Chemical Industries, Ltd. Method for expanding hematopoietic stem cells using heterocyclic compound
RU2485112C1 (ru) * 2012-04-26 2013-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" 4-(4-бромфенил)-4-оксо-2-{[3-(этоксикарбонил)-4,5-диметилтиен-2-ил]амино}-2-бутеновая кислота, обладающая противовоспалительной и анальгетической активностью

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350771B1 (en) * 1996-12-24 2002-02-26 Rhone-Poulenc, Inc. Pesticidal 1-arylpyrazoles
CN1279668A (zh) * 1997-11-18 2001-01-10 帝人株式会社 环胺衍生物及其作为药物的用途
ATE308985T1 (de) * 1999-05-18 2005-11-15 Teijin Ltd Heilmittel und vorbeugung für mit chemokinen verbundenen erkrankungen
AU1462201A (en) * 1999-11-05 2001-06-06 Smithkline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
CA2436288A1 (en) * 2000-12-19 2002-06-27 Smithkline Beecham Corporation Thrombopoietin mimetics
EP1478364B1 (en) * 2001-11-07 2009-09-16 Quonova, LLC Selective antibacterial agents
UA82695C2 (uk) * 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматичні сполуки як активатори рецептора тромбопоетину

Also Published As

Publication number Publication date
JPWO2006062247A1 (ja) 2008-06-12
WO2006062247A1 (ja) 2006-06-15

Similar Documents

Publication Publication Date Title
TW200633984A (en) Amide compounds and activators of thrombopoietin receptor
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
SG164288A1 (en) Chemokine receptor antagonists
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
TW200633712A (en) Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
RS92004A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
TW200626145A (en) Heterocyclic compounds and thrombopoietin receptor activators
MXPA05012248A (es) Fenil quinolinas y su uso como moduladores del receptor de estrogeno.
TW200613302A (en) Nk1 antagonists
MX2009010082A (es) Derivados y composiciones que comprenden isoindolina 4'-o-sustituida y metodos para utilizar la misma.
WO2007117465A3 (en) Indazole compounds
TW200744588A (en) Pharmaceutical composition for external use
TW200745056A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
NZ588121A (en) Novel estrogen receptor ligands
TW200612925A (en) Prodrug substituted benzoxazoles as estrogenic agents
IL205354A0 (en) Spiroindolinone derivatives
TW200727920A (en) New regimens for oral monophasic contraceptives
TNSN08191A1 (en) Kinase inhibitors
MX2010006230A (es) Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3.
MX2007007152A (es) Antagonista de naurocinina-1 con anillo en puente.
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
TW200633998A (en) Substituted heterocyclic compounds and thrombopoietin receptor activators
HK1145172A1 (en) (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
TW200633997A (en) Substituted heterocyclic compounds and thrombopoietin receptor activators
ZA200801332B (en) Pentacyclic kinase inhibitors